The Phase I Study of SIG001 Antibody on Cancer Therapy.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Phase I Study of SIG001 Antibody on Cancer Therapy.	Neoplams	Not yet recruiting	Phase 1	2026-03-20		NCT07486700

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Zhejiang University	201
Guangzhou SIG Biomedical Technology Co., Ltd.	1
Peking Union Medical College Hospital	417
Peking University	124
Peking University Cancer Hospital & Institute	189
Tianjin Medical University Cancer Institute and Hospital	287

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	55

Clinical trials